Photo: Ola Ericson/

Programme 2024

The programme is preliminary and is subject to change
Latest update: 30 January 2024

Monday 5 February

11:00-11:10 Welcome
Andreas Schult, GothenburgPer StÄl, Stockholm
11:10-12:00 State-of-the-art: Alpha-1 antritrypsin deficiency
Vibeke Brix Christensen, Copenhagen
12:00-12:30 Pediatric hepatology consultation: a case report in the interface between the clinic and genetics
Henrik Arnell, StockholmMikael Oscarsson, Stockholm
13:30-14:10 State of the Art: ICU-care for ACLF
Thierry Gustot, Brussels
14:10-14:40 Cirrhotic cardiomyopathy, does it exist in real life?
SĂžren MĂžller, Copenhagen
14:40-15:10 Ammonium in liver disease
Mattias Lissing, Stockholm
15:10-15:40 Coffee break & exhibition
15:40-16:05 Prediction and prevention of the first episode of overt HE
Stergios Kechagias, Linköping
16:05-16:30 Sarcopenia, a silent predator in cirrhosis
Anna Cederborg, Gothenburg
Diagnosis and clinical perspective on Wilson’s disease
Piotr Socha, Warsaw
Monitoring and treatment in Wilson’s disease
Thomas Sandahl, Aarhus

Tuesday 6 February

09:00-09:45 Carl-Gustav Groth lecture, sponsored by Sandoz: State-of-the-art: Living donor liver transplantation
Mark Cattral, Toronto
09:45-10:10 Should we aim for adult living liver donation in Sweden? Pros and cons
Carl Jorns, StockholmWilliam Bennet, Gothenburg
10:10-10:30 Living liver donors – the donors perspective
Annette Lennerling, Gothenburg
10:30-11:00 Coffee break & exhibition
09:00-09:45 STE20-Type Kinases Promote the Progression of Hepatocellular Carcinoma
Margit Mahlapuu, Gothenburg
09:45-10:00 Fire Talk: Regression of steatosis and neoplastic lesions induced by TG68, a novel thyroid hormone receptor-beta (THRÎČ) agonist, in a MASLD-associated hepatocarcinogenesis
Andrea Marco Caddeo, Gothenburg
10:00-10:15 Fire Talk: Colorectal liver metastases – Knowing the capsule of good prognosis
Carlos FernĂĄndez Moro, Stockholm
10:15-10:30 Fire Talk: 3D high-resolution imaging identifies stage-specific cholangiocyte cilia morphologies
Lenka Belicova, Stockholm
10:30-11:00 Coffee break & exhibition
11:00-11:30 A distinct population of human liver resident macrophages protect against metabolic impairments associated with obesity
Emelie Barreby, Stockholm
11:30-11:45 Fire Talk: Global 13C tracing and metabolic flux analysis of intact human liver tissue ex vivo
Cecilia Jönsson, Linköping
11:45-12:00 Fire Talk: 3D printed microperfused and mesoscale human liver model with physiological oxygen gradient and hepatic zonation
Nayere Taebnia, Stockholm
12:00-12:30 Pronounced vasculature phenotypes in new mouse models with ALGS and BA-associated mutations in Jag1
Jan Masek, Prague
11:00-11:15 Persistent ascites after liver transplantation – Surgical causes and solutions
Niclas Kvarnström, Gothenburg
11:15-11:30 Splenic artery (steal) syndrome, small for size and portal hyperperfusion – All the same?
Markus GĂ€bel, Gothenburg
11:30-11:55 Radiological interventions in persistent ascites after liver transplantation
Martin Delle, Stockholm
11:55-12:15 Hepatic artery stenosis/thrombosis: to treat or not to treat?
Antonio Romano, Stockholm
12:15-12:30 Questions & discussion
13:30-14:00 How do we optimize the cirrotic patient thorugh surgical procedures – the anesthiologist point of view
Peter Larsson, Gothenburg
14:00-14:30 How to enhance recovery after liver surgery
Nicolai Schultz, Copenhagen
14:30-15:00 Minimal invasive approach for resection in the cirrotic liver
Niclas Kvarnström, Gothenburg
15:00-15:30 Coffee break & exhibition
15:30-16:15 Liver regeneration – insights on the small-for-size syndrome
Isabelle Leclercq, Brussels
16:15-16:45 Postoperative liver failure – Surgeon’s point of view / Hepatologist’s point of view
Stefan Gilg, StockholmStaffan Wahlin, Stockholm
16:45-17:00 Patient case and discussion
13:30-13:45 VĂ€lkomna till leverveckan – omvĂ„rdnad 1, Resultat frĂ„n TransplantationsĂ„ret
Malin Aram, StockholmKarin Edlund, Gothenburg
13:45-14:30 ”Mitt liv, min hĂ€lsa” – en verktygslĂ„da för egenvĂ„rdsstöd efter transplantation
Anna Forsberg, Lund
14:30-15:00 NASH/ASH – En indikationen för transplantation som ökar?
Hannes Hegmar, Stockholm
15:00-15:30 Coffee break & exhibition
15:30-16:00 Hur hantera beroendeproblematik efter transplantation med indikation alkoholcirros
Tilda Hultqvist, StockholmKarin Jarl, Stockholm
16:00-17:00 Patientfall
Gösta Ekwall, Karlskrona
13:30-13:35 Welcome
Thomas Casswall, StockholmNils Ekvall, Gothenburg
13:35-15:00 Update on portal vein thrombosis and portal hypertension. Guidelines, investigation, prevention, and treatment.
Nils Ekvall, GothenburgThomas Casswall, StockholmMartin Delle, StockholmLilia Martinez de la Maza, StockholmMaria Magnusson, Stockholm
15:00-15:30 Coffee break & exhibition
15:30-15:45 ERN-rare liver: New register for Biliary Atresia and conclusions from the Nordic AILD-study
Björn Fischler, Stockholm
15:45-16:25 Ongoing studies in pediatric hepatology: Primary sclerosing cholangitis; from childhood to adulthood, Immunology in cholestatic infants, Biliary Atresia and Prematurity in the Nordic Countries, Immune system in children with Alagille syndrome
Anna JerregÄrd Skarby, StockholmAfrodite Psaros Einberg, StockholmUlrika Liliemark, StockholmFeven Dawit, Stockholm
16:25-16:30 Next year’s SLW in Gothenburg 2025
Nils Ekvall, Gothenburg

Wednesday 7 February

09:00-09:30 Childhood obesity and risk of future liver disease-Epidemiological aspects
Emilia Hagman, Stockholm
09:30-10:00 Alcohol is an important risk factor for progression of concomitant liver disease
Fredrik Åberg, Helsinki
10:00-10:30 How can we best use elastography in clinical practice
Mattias Ekstedt, Linköping
10:30-11:00 Coffee break & exhibition
09:00-09:05 VÀlkomna till OmvÄrdnad 2
Malin Aram, StockholmKarin Edlund, Gothenburg
09:05-09:35 Metabola sjukdomar hos barn och val av tidpunkt för transplantation
Henrik Arnell, Stockholm
09:35-10:05 Etiska rĂ„det – vad innebĂ€r det?
Ulrika HĂ€renstam, Gothenburg
10:05-10:30 Vad ligger till grund för beslutsfattande utifrÄn ett etiskt perspektiv
Ulrika HĂ€renstam, GothenburgHenrik Arnell, Stockholm
10:30-11:00 Coffee break & exhibition
11:00-11:45 Patientfall
Sandra Green, Stockholm
11:45-12:15 IVA-vÄrd efter levertransplantation ur ett omvÄrdnadsperspektiv
Anna Östbring, StockholmCamilla Gfrörer, Stockholm
12:15-12:30 Summering & utvÀrdering
Malin Aram, StockholmKarin Edlund, Gothenburg
11:00-11:50 The changing panorama and management of liver disease in Europe
Tom Hemming Karlsen, Oslo
11:50-12:30 Challenges in hepatology and liver transplantation- a discussion between two newly appointed professors
Annika Bergquist, StockholmGabriel Oniscu, Stockholm
13:30-14:05 Fighting NAFLD pandemic- role of innovative dietary interventions
Marie Löf, Stockholm
14:05-14:30 Can we really trust in PEth in clinical practice?
Stergios Kechagias, Linköping
14:30-14:55 Time for pharmacological treatment of NAFLD
Hannes Hagström, Stockholm
14:55-15:00 Closing remarks
Andreas Schult, GothenburgPer StÄl, Stockholm